| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |